Financial News Based On Company



Advertisement

DaVita HealthCare ( DVA ) Outperforms Broader Market: What You Need to Know

https://www.zacks.com/stock/news/2504644/davita-healthcare-dva-outperforms-broader-market-what-you-need-to-know
DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

https://www.zacks.com/stock/news/2484770/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.

Buffett Bought More of This High-Yield Dividend Stock in Q1. Should You Buy It, Too?

https://www.fool.com/investing/2025/05/22/buffett-bought-high-yield-dividend-stock/
Just because Warren Buffett is wary of the stock market right now doesn't mean he isn't buying any stocks. In the first quarter of 2025, the legendary investor added to Berkshire Hathaway's stakes in 12 stocks and initiated a new position in another.The list included a high-yield dividend stock ...

Made in the USA: Warren Buffett Sells Out of 1 International Stock and Doubles His Stake in 2 U.S. Companies

https://www.fool.com/investing/2025/05/20/made-in-the-usa-warren-buffett-sells-out-of-1-inte/
Investors eagerly anticipate the Berkshire Hathaway quarterly 13F filings, which detail the company's current equity holdings. It provides investing inspiration for individual investors, but more than that, it's a window into what Chief Executives Officer Warren Buffett might be thinking about ...

Warren Buffett Just Sold These 8 Stocks, One of Which Remains a Phenomenal Bargain ( and a Top Holding of Mine )

https://www.fool.com/investing/2025/05/18/warren-buffett-just-sold-8-stocks-1-is-a-bargain/
The Oracle of Omaha has been a big-time seller of stocks for 10 consecutive quarters -- but there's one sale he may regret.
Advertisement

Advertisement

DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract

https://www.zacks.com/stock/news/2468727/davita-stock-down-despite-q1-earnings-beat-margins-contract
Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.

DaVita HealthCare ( DVA ) Q1 Earnings and Revenues Beat Estimates

https://www.zacks.com/stock/news/2467145/davita-healthcare-dva-q1-earnings-and-revenues-beat-estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 14.29% and 0.38%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

US Stock Futures Rise As US, China Agree To 90-Day Tariff Pause: 'Wider Earnings Growth Should Drive More Balanced Market Performance,' Says Expert - Alibaba Gr Hldgs ( NYSE:BABA ) , Baidu ( NASDAQ:BIDU )

https://www.benzinga.com/government/regulations/25/05/45342343/us-stock-futures-rise-as-us-china-agree-to-90-day-tariff-pause-wider-earnings-growth-shoul
U.S. stock futures jumped on Monday after a muted day of trade on Friday. Futures of major benchmark indices were trading over 2% in premarket. U.S. and China announced a 90-day truce to pause the reciprocal tariffs on Monday and revised it from 125% to 10%.

Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone - DaVita ( NYSE:DVA ) , Fox ( NASDAQ:FOX )

https://www.benzinga.com/news/earnings/25/05/45341868/dow-falls-over-100-points-also-records-weekly-loss-fear-greed-index-remains-in-greed-zone
The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, while the index remained in the "Greed" zone on Friday. U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 100 during the session ahead of trade talks between the US and ...

Fox, NRG Energy And 3 Stocks To Watch Heading Into Monday - DaVita ( NYSE:DVA ) , Fox ( NASDAQ:FOX )

https://www.benzinga.com/25/05/45341185/fox-nrg-energy-and-3-stocks-to-watch-heading-into-monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Fox Corporation FOX to report quarterly earnings at 91 cents per share on revenue of $4.18 billion before the opening bell, according to data ...
Advertisement

Advertisement

Dow Futures Rally Over 400 Points As US, China 'Come To Agreement' In Geneva Trade Talks - Monday.Com ( NASDAQ:MNDY ) , DaVita ( NYSE:DVA )

https://www.benzinga.com/markets/25/05/45339384/dow-futures-rally-over-400-points-as-us-china-come-to-agreement-in-geneva-trade-talks
U.S. stock futures rose Sunday evening after weekend trade talks in Geneva signaled potential de-escalation in the ongoing trade war with China. The S&P 500 Futures are up 1.35%, trading at 5,754.50, Nasdaq Futures are trading at 20,515.25, up 1.88%, and finally Dow Jones Futures are up 1.01%, ...

Vystar Develops Revolutionary Leap in Air Purification Utilizing its Patented Hughes Reactor

https://www.globenewswire.com/news-release/2025/05/09/3078309/0/en/Vystar-Develops-Revolutionary-Leap-in-Air-Purification-Utilizing-its-Patented-Hughes-Reactor.html
Boston, MA, May 09, 2025 ( GLOBE NEWSWIRE ) -- Vystar® Corporation ( OTCQB: VYST ) Vystar has completed what it believes to be a revolutionary, next-generation RXAIR prototype using the new Fluid Energy Conversion - Hughes Reactor. The Hughes Reactor was developed by Dr. Bryan Stone, a Vystar ...

Astrana Health, Inc. ( ASTH ) Q1 Earnings and Revenues Lag Estimates

https://www.zacks.com/stock/news/2465580/astrana-health-inc-asth-q1-earnings-and-revenues-lag-estimates
Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of -39.13% and 2.33%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?

https://www.zacks.com/stock/news/2465365/can-revenue-cycle-operations-drive-dva-stock-before-q1-earnings
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.

DaVita HealthCare ( DVA ) Outperforms Broader Market: What You Need to Know

https://www.zacks.com/stock/news/2464568/davita-healthcare-dva-outperforms-broader-market-what-you-need-to-know
DaVita HealthCare (DVA) closed the most recent trading day at $143.96, moving +0.94% from the previous trading session.
Advertisement

Advertisement

LifeStance Health Group ( LFST ) Reports Break-Even Earnings for Q1

https://www.zacks.com/stock/news/2463717/lifestance-health-group-lfst-reports-break-even-earnings-for-q1
LifeStance Health (LFST) delivered earnings and revenue surprises of 100% and 0.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare ( ADUS ) Beats Q1 Earnings Estimates

https://www.zacks.com/stock/news/2462469/addus-homecare-adus-beats-q1-earnings-estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 6.77% and 0.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

DaVita HealthCare ( DVA ) Stock Falls Amid Market Uptick: What Investors Need to Know

https://www.zacks.com/stock/news/2460714/davita-healthcare-dva-stock-falls-amid-market-uptick-what-investors-need-to-know
DaVita HealthCare (DVA) closed at $140.44 in the latest trading session, marking a -0.78% move from the prior day.

Prediction: Warren Buffett Will Reveal an Increase in This Massive Berkshire Hathaway Holding on May 3

https://www.fool.com/investing/2025/04/29/prediction-warren-buffett-will-reveal-an-increase/
This high-yield investment could continue to make up a significant portion of Berkshire's portfolio.

Warren Buffett Absolutely Nailed the Trump-Induced Market Sell-Off. But When Will the Oracle of Omaha Turn Bullish?

https://www.fool.com/investing/2025/04/27/warren-buffett-trump-sell-off-bullish-berkshire/
By now, it's no secret that Warren Buffett and his company Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) absolutely nailed the stock market sell-off caused by President Donald Trump's tariffs and global trade tensions.
Advertisement

Advertisement

DaVita HealthCare ( DVA ) Ascends But Remains Behind Market: Some Facts to Note

https://www.zacks.com/stock/news/2453213/davita-healthcare-dva-ascends-but-remains-behind-market-some-facts-to-note
In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day.

3 No-Brainer Warren Buffett Stocks to Buy Right Now

https://www.fool.com/investing/2025/04/19/3-no-brainer-warren-buffett-stocks-to-buy-right-no/
Here are three of Berkshire Hathaway's favorite stocks.

Why DaVita Stock Got Rocked This Week

https://www.fool.com/investing/2025/04/18/why-davita-stock-got-rocked-this-week/
We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita ( NYSE: DVA ) suffered a hacker ambush in recent days, a situation that spooked many investors. As a result, according to data compiled by S&P Global Market Intelligence, ...

DaVita HealthCare ( DVA ) Stock Declines While Market Improves: Some Information for Investors

https://www.zacks.com/stock/news/2451081/davita-healthcare-dva-stock-declines-while-market-improves-some-information-for-investors
DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close.

The Best Warren Buffett Stocks to Buy With $300 Right Now

https://www.fool.com/investing/2025/04/12/the-best-warren-buffett-stocks-to-buy-with-300-rig/
Through a remarkable career spanning more than 70 years, Warren Buffett has demonstrated a blueprint for investing success. His disciplined approach, focusing on high-quality companies with strong fundamentals, anchored through a long-term perspective, is perhaps more important than ever amid the ...
Advertisement

Advertisement

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and Addus HomeCare

https://www.zacks.com/stock/news/2446480/zacks-industry-outlook-highlights-davita-encompass-health-option-care-health-and-addus-homecare
DaVita, Encompass Health, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

DaVita HealthCare ( DVA ) Gains As Market Dips: What You Should Know

https://www.zacks.com/stock/news/2444952/davita-healthcare-dva-gains-as-market-dips-what-you-should-know
DaVita HealthCare (DVA) closed at $153.36 in the latest trading session, marking a +0.33% move from the prior day.

4 Stocks to Watch in a Dynamic Outpatient Home Health Industry

https://www.zacks.com/commentary/2442600/4-stocks-to-watch-in-a-dynamic-outpatient-home-health-industry
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.

If I Could Only Buy and Hold a Single Stock, This Would Be It

https://www.fool.com/investing/2025/04/06/if-i-could-only-buy-and-hold-a-single-stock-this-w/
Here's one stock that may be able to benefit in a recession.

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

https://www.zacks.com/stock/news/2440768/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now
FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.
Advertisement

Advertisement

DaVita HealthCare ( DVA ) Stock Moves -0.36%: What You Should Know

https://www.zacks.com/stock/news/2440121/davita-healthcare-dva-stock-moves--036-what-you-should-know
In the most recent trading session, DaVita HealthCare (DVA) closed at $153.73, indicating a -0.36% shift from the previous trading day.

DaVita HealthCare ( DVA ) Stock Falls Amid Market Uptick: What Investors Need to Know

https://www.zacks.com/stock/news/2438610/davita-healthcare-dva-stock-falls-amid-market-uptick-what-investors-need-to-know
The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close.

Warren Buffett Sold These 12 Stocks Over the Past 6 Months: Should You Sell Them Too?

https://www.fool.com/investing/2025/03/31/warren-buffett-sold-these-12-stocks-over-the-last/
Warren Buffett is known for the stocks he buys. He's had some big winners through the years. And many of them have helped propel Berkshire Hathaway to deliver a compound annual growth rate of nearly 20% over the past six decades. More recently, though, Buffett has sold more stocks than he's ...

Why Is Chemed ( CHE ) Up 4.5% Since Last Earnings Report?

https://www.zacks.com/stock/news/2436970/why-is-chemed-che-up-45-since-last-earnings-report
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kidney Care Partners Commends Senate Reintroduction of the Restore Protections for Dialysis Patients Act

https://www.benzinga.com/pressreleases/25/03/r44525476/kidney-care-partners-commends-senate-reintroduction-of-the-restore-protections-for-dialysis-patien
Washington, DC March 27, 2025 -- ( PR.com ) -- Kidney Care Partners ( KCP ) - the nation's largest non-profit, non-partisan kidney care coalition dedicated to protecting access and representing patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant ...
Advertisement

Advertisement

DaVita HealthCare ( DVA ) Rises As Market Takes a Dip: Key Facts

https://www.zacks.com/stock/news/2435889/davita-healthcare-dva-rises-as-market-takes-a-dip-key-facts
In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day.

DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

https://www.zacks.com/stock/news/2435730/davita-stock-declines-12-in-3-months-heres-how-to-play
DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors.

DaVita HealthCare ( DVA ) Exceeds Market Returns: Some Facts to Consider

https://www.zacks.com/stock/news/2435162/davita-healthcare-dva-exceeds-market-returns-some-facts-to-consider
DaVita HealthCare (DVA) reachead $150.78 at the closing of the latest trading day, reflecting a +0.25% change compared to its last close.

House Reintroduction of the Restore Protections for Dialysis Patients Act Commended by Kidney Community

https://www.benzinga.com/pressreleases/25/03/r44465158/house-reintroduction-of-the-restore-protections-for-dialysis-patients-act-commended-by-kidney-comm
Washington, DC March 24, 2025 -- ( PR.com ) -- Kidney Care Partners ( KCP ) - the nation's largest non-profit, non-partisan kidney care coalition dedicated to protecting access and representing patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant ...

DaVita HealthCare ( DVA ) Increases Yet Falls Behind Market: What Investors Need to Know

https://www.zacks.com/stock/news/2432444/davita-healthcare-dva-increases-yet-falls-behind-market-what-investors-need-to-know
The latest trading day saw DaVita HealthCare (DVA) settling at $149.83, representing a +0.31% change from its previous close.
Advertisement

Advertisement

DaVita HealthCare ( DVA ) Suffers a Larger Drop Than the General Market: Key Insights

https://www.zacks.com/stock/news/2429992/davita-healthcare-dva-suffers-a-larger-drop-than-the-general-market-key-insights
DaVita HealthCare (DVA) closed the most recent trading day at $141.12, moving -1.06% from the previous trading session.

Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom' - Agilent Technologies ( NYSE:A ) , DaVita ( NYSE:DVA )

https://www.benzinga.com/markets/equities/25/03/44160328/goldman-sachs-cuts-earnings-growth-outlook-sees-investors-move-from-excitement-to-boredom
David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs, has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends. What Happened: On CNBC's 'Squawk on the Street', Kostin discussed his revised earnings growth forecast and market ...

Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF ( JPME ) a Strong ETF Right Now?

https://www.zacks.com/stock/news/2423372/is-jpmorgan-diversified-return-us-mid-cap-equity-etf-jpme-a-strong-etf-right-now
Smart Beta ETF report for ...

Warren Buffet's Berkshire Hathaway Further Trims Its Stake In Davita By 2%. Sells Additional Shares Worth $116 Million - DaVita ( NYSE:DVA )

https://www.benzinga.com/25/02/43874883/warren-buffets-berkshire-hathaway-further-trims-its-stake-in-davita-by-2-sells-additional-shares-worth-116-millio
Warren Buffett's investment firm, Berkshire Hathaway BRK BRK, has offloaded a 2% stake in dialysis service provider, DaVita Inc. DVA. The transaction, executed between February 14 and 19, is valued at around $116 million. What Happened: A Form 4 filing with the U.S.

Warren Buffett Just Gave Investors a $46 Million Warning About the Stock Market

https://www.fool.com/investing/2025/02/19/warren-buffett-just-gave-investors-a-46-million-wa/
Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) recently gave investors an updated look at its widely followed stock portfolio as of the end of the fourth quarter, and some of the moves weren't surprising. For example, many investors expected that Warren Buffett and his team might trim the ...
Advertisement

Advertisement

Why DaVita Inc Stock Is Plummeting Today

https://www.fool.com/investing/2025/02/14/why-davita-inc-stock-is-plummeting-today/
Shares of DaVita Inc ( NYSE: DVA ) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day. The drop comes as the S&P 500 lost 0.1%, and the Nasdaq composite was up 0.4%.DaVita, a large operator of kidney dialysis clinics, ...

DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand

https://www.zacks.com/stock/news/2416324/dva-stock-down-in-pre-market-despite-q4-earnings-beat-margins-expand
Robust segmental revenues drive DaVita's fourth-quarter 2024 performance despite a per-day decrease of the total U.S. dialysis treatments on a sequential basis.

Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Applied Mat ( NASDAQ:AMAT ) , Clearwater Paper ( NYSE:CLW )

https://www.benzinga.com/trading-ideas/movers/25/02/43728251/applied-materials-informatica-clearwater-paper-and-other-big-stocks-moving-lower-in-fridays-
U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Friday. Shares of Applied Materials, Inc. AMAT fell sharply in today's pre-market trading after the company issued second-quarter revenue guidance below estimates.

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

https://www.cnbc.com/2025/02/14/warren-buffetts-berkshire-hathaway-sells-some-davita-shares-fall-on-disappointing-guidance.html
DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

DaVita Plunges Over 10% In Friday Pre-Market. What's Wrong? - DaVita ( NYSE:DVA )

https://www.benzinga.com/general/health-care/25/02/43725529/davita-plunges-over-10-in-friday-pre-market-after-warren-buffett-cuts-stake-in-one-of-berkshi
The shares of DaVita Inc.DVA plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for 2025 as it announced its results after the market closed on Thursday.
Advertisement

Advertisement

Advertisement